Non-Acceptance of a Proposed Compound. (a) In the event that Novartis, in its reasonable discretion, determines that a Proposed Compound does not meet the Acceptance Criteria, it shall so notify Infinity in writing (the “Non-Acceptance Notice”) within [**] calendar days of the delivery of such Proposed Compound (the “Non-Acceptance Notice Period”).
Appears in 4 contracts
Samples: Collaboration and Option Agreement, Collaboration and Option Agreement (Infinity Pharmaceuticals, Inc.), Collaboration and Option Agreement (Discovery Partners International Inc)
